破裂性降主动脉瘤腔内修复术后的转归:一项全国多中心研究
该研究分析了瑞典六家大学血管中心2000年至2015年间140例接受TEVAR的破裂性降主动脉瘤患者,30天内45%发生主要并发症,卒中最多见(14.7%),1个月生存率80.0%,5年降至31.9%,年龄、卒中史、既往主动脉手术及术后大出血、卒中、肾衰竭与死亡相关。
要点
- TEVAR治疗rDTAA短期生存可接受(1个月80.0%),但长期生存差(5年31.9%)。
- 术后30天内45%发生主要并发症,卒中(14.7%)、截瘫(9.6%)、大出血(9.6%)常见。
- 术后大出血、卒中、肾衰竭及年龄、卒中史、既往主动脉手术与死亡独立相关。
核心结论
- 全国多中心研究显示rDTAA患者TEVAR后短期生存可接受但长期生存差。
- 充分的近远端锚定区对技术成功重要,高危患者及术后并发症需进一步关注以改善预后。
研究设计与样本
- 纳入140例接受TEVAR的rDTAA患者,平均年龄74.1±8.8岁,56%为男性,动脉瘤大小64.8±19 mm。
- 采用Kaplan-Meier法和多变量Cox回归分析结局。
主要发现
- 53例(37.9%)覆盖左锁骨下动脉,25例(17.9%)行弓部血管重建。
- 30天内61/136例(45%)发生主要并发症,卒中20例(14.7%),截瘫13例(9.6%),大出血13例(9.6%)。
- 随访期内漏内漏发生率为22.1%(30/136;14例1a型,6例1b型,10例未定义)。
- 27/137例(19.7%)患者需再干预(共31次)。
- Kaplan-Meier估计生存率:1个月80.0%,3个月71.7%,1年65.3%,3年45.9%,5年31.9%。
临床怎么用
- 对rDTAA行TEVAR需确保充分的近远端锚定区以提高技术成功率。
- 术后应密切监测并处理大出血、卒中、肾衰竭等并发症以改善生存。
- 高龄、卒中史、既往主动脉手术患者属高危人群,需个体化评估与加强管理。
局限性
- 回顾性研究设计。
- 样本量有限(140例)。
- 中位随访时间17.0个月(范围0-132个月),部分患者随访时间较短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this multicentre study was to analyse the outcome of thoracic endovascular aortic repair (TEVAR) in patients with ruptured descending thoracic aortic aneurysm (rDTAA). METHODS: This is a nationwide retrospective study including all patients who underwent TEVAR for rDTAA at six major vascular university centres in Sweden between January 2000 and December 2015. Outcome measures were analysed using Kaplan-Meier estimator and multivariable Cox regression. RESULTS: There were 140 patients (age [mean ± SD] 74.1 ± 8.8 years; 56% men; aneurysm size 64.8 ± 19 mm), with rDTAA. In 53 patients (37.9%), the left subclavian artery was covered, and in 25 patients (17.9%) arch vessel revascularisation was performed. In total, 61/136 patients (45%) had a major complication within 30 days post TEVAR. Stroke (n = 20; 14.7%) was the most common complication, followed by paraplegia (n = 13; 9.6%) and major bleeding (n = 13; 9.6%). TEVAR related complications during follow up included endoleaks 22.1% (30/136; 14 type 1a, six type 1b, 10 not defined). In total, re-interventions (n = 31) were required in 27/137 (19.7%) patients. The median follow up time was 17.0 months (range 0-132 months). The Kaplan-Meier estimated survival was 80.0% at one month, 71.7% at three months, 65.3% at one year, 45.9% at three years, and 31.9% at five years. Age (HR 1.03; 95% CI 1.00-1.07; p = .046), history of stroke (HR 2.35; 95% CI 1.19-4.63; p = .014), previous aortic surgery (HR 2.11; 95% CI 1.15-3.87; p = .016) as well as post-operative major bleeding (HR 4.40; 95% CI 2.20-8.81; p = .001), stroke (HR 2.63; 95% CI 1.37-5.03; p = .004), and renal failure (HR 8.25; 95% CI 2.69-25.35; p = .001) were all associated with mortality. CONCLUSIONS: This nationwide multicentre study of patients with rDTAA undergoing TEVAR showed acceptable short- but poor long-term survival. Adequate proximal and distal aortic sealing zones are important for technical success. High risk patients and post-operative complications need to be further addressed in an effort to improve outcome.
引用
- Hammo S, Larzon T, Hultgren R, et al. Outcome After Endovascular Repair of Ruptured Descending Thoracic Aortic Aneurysm: A National Multicentre Study. Eur J Vasc Endovasc Surg. 2019. PMID: 30910493. doi:10.1016/j.ejvs.2018.10.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。